In this study, multiplex immunofluorescence (mIF) was utilized to characterize and quantify Trm, Tbys, CD4+ T cells, and their subpopulations in TIME of pre- and post-treatment specimens from NSCLC patients. The gene discussed is CD4; the disease is non-small cell lung carcinoma.